Welcome, this website is intended for all international healthcare professionals in uro-oncology. By clicking the link below you are declaring and confirming that you are a healthcare professional.

As of January 1st, 2018 the responsibility for this Resource Centre has been assumed by the European Association of Eurology


The European Association of Urology is proud to present URO ONCO, the online educational platform for all healthcare professionals in uro-oncology.

URO ONCO provides up-to-date information on developments in the field of urological malignancies. With urological tumours presenting three of the ten most commonly found cancers, the need for up-to-date cancer management knowledge is essential for urologists

ASCO 2017 highlights and editor recommendations

  • Selected meeting abstracts - including editorial comment
  • Expert interviews on a range of Uro-oncology topics including
  • News reports from the ASCO Annual meeting
  • Related ASCO 2017 resources

Expert interviews on clinical trial results and breaking news in uro-oncology from ASCO Annual meeting

Latest Headlines in Prostate

Latest Headlines in Bladder

Latest Headlines in Kidney

  • Bosniak Classification for Complex Renal Cysts Reevaluated: A Systematic Review

    Schoots IG, Zaccai K, Hunink MG, Verhagen PCMS.

    J Urol. 2017 Jul;198(1):12-21.

    Editorial comment from Piotr Chlosta:
    In a systematic review evaluating Bosniak classification system for complex renal cysts, the authors conclude that its effectiveness was high for categories II, IIF and IV, whereas low for category III. In category III, surgical overtreatment rate was 49% because of benign pathology. This, together with good oncological outcomes of Bosniak III cysts might suggest that surveillance could be an alternative approach for consideration in this group, warranting further studies to assess safety of surveillance strategy.

  • Cryoablation versus Partial Nephrectomy for Clinical T1b Renal Tumors: A Matched Group Comparative Analysis

    European Urology, Volume 71, Issue 1, January 2017, Pages 111 - 117


    Editorial comment from Piotr Chlosta: Patients treated with cryoablation(CA) for cT1b renal tumors had a significantly higher rate of local cancer recurrence at 1 year compared to those treated with partial nephrectomy (PN). The authors found a higher but not significantly different postoperative complication rate for the PN group, a significantly higher local recurrence rate for the CA group, and similar overall and cancer-specific survival. The role of CA for cT1b RCC need to be determined.

Editor’s Introduction to URO ONCO

Introduction to URO ONCO Resource Centre from the Editor, Prof. Piotr Chlosta

Expert interviews on clinical trial results and breaking news in uro-oncology from ASCO Annual meeting

EAU 2017 Scientific Programme and Sessions

View the Scientific Programme and Sessions of the 2017 EAU Annual Congress, Munich, Germany.

Congress Planner

EAU Guidelines